ProfileGDS4718 / 32625_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 58% 58% 70% 56% 60% 49% 57% 56% 62% 59% 59% 62% 57% 54% 52% 56% 60% 58% 54% 70% 57% 58% 54% 56% 59% 55% 63% 56% 59% 58% 56% 55% 64% 56% 56% 56% 59% 58% 57% 69% 59% 55% 56% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9718258
GSM549102patient 115, normal, homogenized [OPG study]5.9806558
GSM549104patient 119, normal, homogenized [OPG study]6.9516570
GSM549108patient 138, normal, homogenized [OPG study]5.8973556
GSM549119patient 077, normal, homogenized [OPG study]6.1399560
GSM549133patient 032, cancer, homogenized [OPG study]5.377249
GSM549139patient 042, cancer, homogenized [OPG study]5.9207657
GSM549099patient 107, normal, homogenized [OPG study]5.8748856
GSM549109patient 139, normal, homogenized [OPG study]6.260462
GSM549110patient 046, normal, homogenized [OPG study]6.052159
GSM549114patient 063, normal, homogenized [OPG study]5.978459
GSM549122patient 082, normal, homogenized [OPG study]6.2571562
GSM549134patient 033, cancer, homogenized [OPG study]5.8971357
GSM549136patient 036, cancer, homogenized [OPG study]5.7020554
GSM549140patient 044, cancer, homogenized [OPG study]5.6022152
GSM549111patient 047, normal, homogenized [OPG study]5.8882356
GSM549113patient 057, normal, homogenized [OPG study]6.1156460
GSM549132patient 031, cancer, homogenized [OPG study]5.9701358
GSM549137patient 038, cancer, homogenized [OPG study]5.7439454
GSM549142patient 047, cancer, homogenized [OPG study]6.8565670
GSM549100patient 110, normal, homogenized [OPG study]5.939357
GSM549107patient 135, normal, homogenized [OPG study]5.9716858
GSM549115patient 068, normal, homogenized [OPG study]5.6907254
GSM549116patient 072, normal, homogenized [OPG study]5.8718756
GSM549120patient 078, normal, homogenized [OPG study]6.0361259
GSM549131patient 030, cancer, homogenized [OPG study]5.7469555
GSM549118patient 074, normal, homogenized [OPG study]6.3234963
GSM549129patient 027, cancer, homogenized [OPG study]5.9210456
GSM549123patient 088, normal, homogenized [OPG study]6.0506559
GSM549124patient 006, cancer, homogenized [OPG study]6.0038558
GSM549126patient 015, cancer, homogenized [OPG study]5.8392156
GSM549128patient 025, cancer, homogenized [OPG study]5.8381855
GSM549103patient 117, normal, homogenized [OPG study]6.4228564
GSM549117patient 073, normal, homogenized [OPG study]5.8234456
GSM549138patient 041, cancer, homogenized [OPG study]5.8762856
GSM549141patient 045, cancer, homogenized [OPG study]5.836556
GSM549130patient 028, cancer, homogenized [OPG study]6.0538959
GSM549101patient 111, normal, homogenized [OPG study]5.9997558
GSM549105patient 128, normal, homogenized [OPG study]5.9464757
GSM549106patient 134, normal, homogenized [OPG study]6.8779669
GSM549112patient 048, normal, homogenized [OPG study]6.0463159
GSM549125patient 011, cancer, homogenized [OPG study]5.8251655
GSM549127patient 024, cancer, homogenized [OPG study]5.8904456
GSM549135patient 035, cancer, homogenized [OPG study]5.7556455